ArticleFuture oncology (London, England)2024

Sitravatinib in patients with solid tumors selected by molecular alterations: results from a Phase Ib study.

Lyudmila Bazhenova et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.